Progressive bifocal chorioretinal atrophy
Progressive Bifocal Chorioretinal Atrophy (PBCRA) is a rare, inherited eye disorder characterized by progressive loss of vision due to atrophy of the choroid and retina. This condition typically manifests in two distinct areas of the eye, leading to its classification as "bifocal." The disease progression leads to a gradual deterioration of the photoreceptors, which are critical for vision, particularly affecting the central and peripheral visual fields.
Symptoms
The primary symptoms of Progressive Bifocal Chorioretinal Atrophy include a progressive loss of visual acuity, difficulties with night vision, and a narrowing of the visual field. Patients may also experience photophobia, or light sensitivity, and, in some cases, complete blindness. The onset of symptoms usually occurs in childhood or early adolescence.
Causes
PBCRA is a genetic disorder, inherited in an autosomal recessive manner. This means that the condition occurs when an individual inherits two copies of the mutated gene, one from each parent. The specific genes involved in PBCRA have not been fully identified, making genetic counseling and prediction of the disease challenging.
Diagnosis
Diagnosis of Progressive Bifocal Chorioretinal Atrophy is primarily based on clinical examination, including a detailed patient history and a comprehensive eye examination. Imaging techniques such as Fundus photography, Fluorescein angiography, and Optical Coherence Tomography (OCT) are crucial for visualizing the extent of chorioretinal atrophy and confirming the diagnosis. Genetic testing may also be recommended to identify the presence of specific genetic mutations associated with the condition, although the availability of such testing is limited due to the rarity of the disease.
Treatment
There is currently no cure for Progressive Bifocal Chorioretinal Atrophy. Treatment focuses on managing symptoms and maximizing the patient's remaining vision. This may include the use of low vision aids, such as magnifying glasses or specialized electronic devices, and adaptive training to help individuals adjust to their visual limitations. Regular monitoring by an ophthalmologist is essential to address any complications that may arise, such as the development of neovascularization or secondary glaucoma.
Prognosis
The prognosis for individuals with Progressive Bifocal Chorioretinal Atrophy varies depending on the severity of the condition and the age at onset. While the disease is progressive, leading to a gradual decline in vision, many patients retain a degree of functional vision well into adulthood. Early diagnosis and intervention can help to optimize visual function and improve quality of life.
NIH genetic and rare disease info
Progressive bifocal chorioretinal atrophy is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Progressive bifocal chorioretinal atrophy
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian